EMPTX | VEIEX | EMPTX / VEIEX | |
Total Expense Ratio | 0.25 | 0.29 | 86% |
Annual Report Gross Expense Ratio | 1.20 | 0.29 | 414% |
Fund Existence | 7 years | 31 years | - |
Gain YTD | 24.665 | 17.312 | 142% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 25000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 358M | 127B | 0% |
Annual Yield % from dividends | 2.82 | 2.59 | 109% |
Returns for 1 year | 22.11 | 18.84 | 117% |
Returns for 3 years | 36.11 | 33.33 | 108% |
Returns for 5 years | 4.62 | 29.25 | 16% |
Returns for 10 years | N/A | 84.28 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MSMFX | 16.20 | 0.60 | +3.85% |
Morgan Stanley Inst Discovery C | |||
ECMGX | 23.16 | 0.73 | +3.25% |
Eaton Vance Tx-Mgd Small-Cap C | |||
FFICX | 65.44 | 0.95 | +1.47% |
American Funds Invmt Co of Amer F3 | |||
ASICX | 26.50 | 0.27 | +1.03% |
Invesco Asia Pacific Equity C | |||
JFNIX | 69.72 | 0.61 | +0.88% |
Janus Henderson Global Life Sciences I |